Fee-charging Standards for Reviewing the Registration of Western Medicines Article 8

Review fees for each Letter of inquiry are as below:1. Inquiry about registration of drug (clinical trial included), classification of products and quality inspection of medicament manufacturer and western pharmaceuticals distributor: TWD 5,000.2. Inquiry about registration of drug (clinical trial included), classification of combination products and technical documents review: TWD 10,000.3. Inquiry about application of drug counseling project: TWD 30,000.4. Inquiry about retrieving data from national adverse drug reaction database: TWD 5,000.5. The application for priority review designation, accelerated approval designation, and breakthrough treatment designation: TWD 30,000.
中文原文 西藥查驗登記審查費收費標準第8條
辦理藥品相關案件函詢者,每件應繳納之審查費如下:
一、藥品(含臨床試驗)等查驗登記、一般藥品產品管理屬性判定、藥物製造及西藥運銷品質檢查相關函詢,新臺幣五千元。
二、藥品(含臨床試驗)等查驗登記及複合性藥物判定相關函詢,涉及技術性資料審查,新臺幣一萬元。
三、函詢納入藥品專案諮詢輔導評估,新臺幣三萬元。
四、函詢全國藥物不良反應通報資料庫資料,新臺幣五千元。
五、優先審查認定、加速核准機制認定、突破性療效認定申請案,新臺幣三萬元。

English translation for reference only; the Chinese text prevails. Not legal advice.